Correlation Between Scharf Global and Health Biotchnology

Can any of the company-specific risk be diversified away by investing in both Scharf Global and Health Biotchnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scharf Global and Health Biotchnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Scharf Global Opportunity and Health Biotchnology Portfolio, you can compare the effects of market volatilities on Scharf Global and Health Biotchnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scharf Global with a short position of Health Biotchnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scharf Global and Health Biotchnology.

Diversification Opportunities for Scharf Global and Health Biotchnology

0.62

Correlation Coefficient

Scharf Global  Health Biotchnology

Poor diversification

The 3 months correlation between Scharf and Health is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Scharf Global Opportunity and Health Biotchnology Portfolio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Health Biotchnology and Scharf Global is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scharf Global Opportunity are associated (or correlated) with Health Biotchnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Health Biotchnology has no effect on the direction of Scharf Global i.e., Scharf Global and Health Biotchnology go up and down completely randomly.

Pair Corralation between Scharf Global and Health Biotchnology

Assuming the 90 days horizon Scharf Global Opportunity is expected to generate 0.94 times more return on investment than Health Biotchnology. However, Scharf Global Opportunity is 1.06 times less risky than Health Biotchnology. It trades about 0.03 of its potential returns per unit of risk. Health Biotchnology Portfolio is currently generating about -0.05 per unit of risk. If you would invest  3,440  in Scharf Global Opportunity on September 26, 2024 and sell it today you would earn a total of  93.00  from holding Scharf Global Opportunity or generate 2.7% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Scharf Global Opportunity  vs.  Health Biotchnology Portfolio

Scharf Global Opportunity

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Scharf Global Opportunity has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong fundamental indicators, Scharf Global is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Health Biotchnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Health Biotchnology Portfolio has generated negative risk-adjusted returns adding no value to fund investors. In spite of latest weak performance, the Fund's forward indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the fund investors.

Pair Trading with Scharf Global and Health Biotchnology

The main advantage of trading using opposite Scharf Global and Health Biotchnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scharf Global position performs unexpectedly, Health Biotchnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Health Biotchnology will offset losses from the drop in Health Biotchnology's long position.

The idea behind Scharf Global Opportunity and Health Biotchnology Portfolio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.